Low Expression of CLEC2B Indicates Poor Prognosis in Melanoma

BACKGROUND: Melanoma is a highly malignant skin tumor with a poor prognosis. Identification of novel biomarkers might potentially reveal the underlying mechanisms of melanoma progression. METHODS: We demonstrated the relationship between pan-cancer CLEC2B expression and melanoma samples in The Cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yanqiu, Li, Yaling, Yan, Hongwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961593/
https://www.ncbi.nlm.nih.gov/pubmed/36851951
http://dx.doi.org/10.2147/CCID.S395854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961593/
https://www.ncbi.nlm.nih.gov/pubmed/36851951
http://dx.doi.org/10.2147/CCID.S395854

Ejemplares similares